Afton Scientific Revenue

About Afton Scientific

Afton Scientific, a recognized leader in sterile injectable manufacturing and contract development and manufacturing organization (CDMO) services, distinguishes itself through unwavering commitment to quality, reliability, and transformative innovation. Over more than two decades, Afton Scientific has supported pharmaceutical companies and emerging biotech innovators worldwide by delivering advanced solutions in aseptic processing, sterile component production, and sophisticated fill/finish operations. Rooted in a mission that champions integrity, collaboration, and continual advancement, Afton Scientific positions itself not simply as a manufacturer but as a strategic partner in the evolving pharmaceuticals landscape. CDMO Expertise: Strategy, Science, and Service As a pioneering CDMO, Afton Scientific offers a broad portfolio of sterile manufacturing solutions spanning clinical trial supply through commercial pharmaceutical production. Clients benefit from end-to-end support encompassing aseptic processing, sterile filling for vials (with pre-filled syringe and cartridge technologies launching in 2026), as well as formulation, quality assurance, and regulatory guidance. This approach allows pharmaceutical partners—large global firms and emerging biotechs alike—to scale innovations from bench to bedside while meeting stringent FDA and global regulatory standards. Our flexible batch-size capacities and state-of-the-art filling lines enable tailored project solutions for biologics, small molecules, and new modalities such as mRNA therapies and specialty injectables. Afton Scientific’s facilities feature isolator-based sterility assurance, ISO-classified environments, and single-use systems designed to minimize contamination risk and optimize product safety.

View contact profiles from Afton Scientific